Anticancer Drug Hypersensitivities

This interactive course is broken down into two sections focusing on common anticancer drug hypersensitivities. In section 1 Dr. Sally Barbour, a clinical pharmacist from Duke University, discusses some of the most common reactions by drug type. In section 2, Dr. Mariana Castells from Brigham and Women’s Hospital, uses an interactive question format to present three patient case studies on reactions to carboplatin, paclitaxel, and rituximab. In each set of questions, users are instructed to select a course of action to help treat the patient. Feedback within the course is tailored to each selected response. At the end of this course, users should be able to:

  • Recognize the clinical presentations of hypersensitivity reactions to platinum drugs, taxanes and monoclonal antibodies
  • Diagnose anaphylaxis and administer its appropriate treatment in the context of a hypersensitivity reaction to chemotherapy or monoclonal antibodies
  • Apply the indications for allergy referral and desensitization procedures in patients with hypersensitivity reactions to chemotherapy or monoclonal antibodies


ACGME Competencies addressed: Medical Knowledge

Note: This course is accessible through iPads as well as personal computers